This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: The Asan Foundation, University of Ulsan Foundation for Industry Cooperation. Active years: 2016.
Company Filing History:
1 out of 84 
1 out of 94 
Years Active: 2016
Title: Innovations of Bongkun Choi in Valve Calcification Treatment.
Introduction
Bongkun Choi is an innovative inventor based in South Korea. He has made significant contributions to the field of medical compositions, particularly in the prevention and treatment of valve calcification. His work focuses on utilizing dipeptidyl peptidase-4 (DPP-4) inhibitors to address this medical condition.
Latest Patents
Bongkun Choi currently holds a patent for a composition aimed at preventing or treating valve calcification, which contains a DPP-4 inhibitor. The invention encompasses various substances that can inhibit the expression of DPP-4 nucleotides or the activity of DPP-4 proteins. This includes DPP-4 antibodies and several inhibitors such as sitagliptin, vildagliptin, saxagliptin, linagliptin, dutogliptin, gemigliptin, alogliptin, anagliptin, evogliptin, berberine, diprotin, and lupeol. Additionally, it covers DPP-4 mRNA anti-sense nucleotides, aptamers, small interfering RNA (siRNA), short hairpin RNA (shRNA), microRNA (miRNA), and RNA interference (RNAi).
Career Highlights
Bongkun Choi has worked with notable organizations, including the Asan Foundation and the University of Ulsan Foundation for Industry Cooperation. His experience in these institutions has contributed to his expertise in the field of medical research and innovation.
Collaborations
Some of his coworkers include Eun-Ju Chang and Jae-Kwan Song, who have collaborated with him on various projects related to his research.
Conclusion
Bongkun Choi's work in developing compositions for preventing or treating valve calcification showcases his innovative approach to medical challenges. His contributions to the field are significant and reflect his dedication to advancing healthcare solutions.